phenobarbital has been researched along with Alogia in 2 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deuel, RK | 1 |
| Lenn, NJ | 1 |
| Dugas, M | 1 |
| Grenet, P | 1 |
| Masson, M | 1 |
| Mialet, JP | 1 |
| Jaquet, G | 1 |
2 other studies available for phenobarbital and Alogia
| Article | Year |
|---|---|
Treatment of acquired epileptic aphasia.
Topics: Aphasia; Child; Epilepsy; Ethosuximide; Female; Humans; Phenobarbital | 1977 |
[Childhood aphasia with epilepsy. Remission with antiepileptic treatment].
Topics: Aphasia; Child; Child, Preschool; Epilepsy, Temporal Lobe; Female; Humans; Phenobarbital; Remission, | 1976 |